Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Post-traumatic stress disorder (PTSD) (Fluoxetine hydrochloride - Post-traumatic stress disorder (PTSD))

Records returned : 8 (on 20 Oct 2025 at 13:12:55). Return to search results for ' Post-traumatic stress disorder (PTSD) '.

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off Label

Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

NICE

Link to the NICE website

Low carbon device

SPC

View the treatment summary for {padindicationname} on https://www.medicines.org.uk

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

1. Fluoxetine hydrochloride

Drug:

Fluoxetine hydrochloride

Indication :

Post-traumatic stress disorder (PTSD)

Status :

Blue

Formulations :

Capsules

Restrictions / Comments:

Important

Off-label use. Initiation and stabilisation by the Mental Health specialist team for a minimum of 3 months before any transfer of prescribing.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Off Label

SPC

2. Fluoxetine hydrochloride

Drug:

Fluoxetine hydrochloride

Indication :

Post-traumatic stress disorder (PTSD)

Status :

Blue

Formulations :

Dispersible tablets
Oral solution

Restrictions / Comments:

Important

Off-label use. Initiation and stabilisation by the Mental Health specialist team for a minimum of 3 months before any transfer of prescribing.

Fluoxetine dispersible tablets are the more cost effective option in patents without dysphagia.

Fluoxetine oral solution and dispersible tablets are clinically interchangable for oral use.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Off Label

SPC

3. Fluoxetine hydrochloride

Drug:

Fluoxetine hydrochloride

Indication :

Post-traumatic stress disorder (PTSD)

Status :

Non Formulary

Formulations :

Tablets

Restrictions / Comments:

Important

Off-label use. Initiation and stabilisation by the Mental Health specialist team for a minimum of 3 months before any transfer of prescribing.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

NFD1

SPC

4. Citalopram

Drug:

Citalopram

Indication :

Post-traumatic stress disorder (PTSD)

Status :

Blue

Formulations :

Oral drops
Tablets

Restrictions / Comments:

Important

Off-label use. Initiation and stabilisation by the Mental Health specialist team for a minimum of 3 months before any transfer of prescribing.

Dose adjustment required for liquid (10mg tablet = 8mg Oral Drops (4 drops) - see SPC for dose equivalence)

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Off Label

SPC

5. Escitalopram

Drug:

Escitalopram

Indication :

Post-traumatic stress disorder (PTSD)

Status :

Blue

Formulations :

Tablets

Restrictions / Comments:

Important

Off-label use. Initiation and stabilisation by the Mental Health specialist team for a minimum of 3 months before any transfer of prescribing.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Off Label

SPC

6. Escitalopram

Drug:

Escitalopram

Indication :

Post-traumatic stress disorder (PTSD)

Status :

Blue

Formulations :

Oral drops
Oro-dispersible tablets

Restrictions / Comments:

Important

Off-label use. Initiation and stabilisation by the Mental Health specialist team for a minimum of 3 months before any transfer of prescribing.

For use where ordinary tablets are not suitable.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Off Label

SPC

7. Paroxetine hydrochloride

Drug:

Paroxetine hydrochloride

Indication :

Post-traumatic stress disorder (PTSD)

Status :

Blue

Formulations :

Tablets

Restrictions / Comments:

Important

Initiation and stabilisation by the Mental Health specialist team for a minimum of 3 months before any request to transfer prescribing responsibility.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

8. Sertraline

Drug:

Sertraline

Indication :

Post-traumatic stress disorder (PTSD)

Status :

Blue

Formulations :

Tablets

Restrictions / Comments:

Important

Initiation and stabilisation by the Mental Health specialist team for a minimum of 3 months before any request to transfer prescribing responsibility.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC